FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Björn Andreasson

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Anatomy

Co-author Network

Publications

TOP 3
Gilles Bonicelli; Khadija Abdulkarim; Björn Andreasson; Peter Johansson; Valérie Jooste; Marc Maynadié; Morgane Mounier; Cédric Rossi; François Girodon
Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.
Elisabeth Ejerblad; Hans M Kvasnicka; Eva Löfvenberg; Berit Markevärn; Mats Merup; Lars Nilssson; Jan Palmblad; Jan Samuelsson; Jürgen Thiele; Björn Andreasson; Magnus Björkholm; Gunnar Birgegård
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up.
Magnus Björkholm; Asa Rangert Derolf; Charlotta Ekstrand; Lynn R Goldin; Fredrik Granath; Malin Hultcrantz; Sigurdur Y Kristinsson; Olle Linder; Claes Malm; Berit Markevärn; Lars Nilsson; Jan Samuelsson; Björn Andreasson; Gunnar Birgegård; Ola Landgren
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Björn Andreasson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gilles Bonicelli; Khadija Abdulkarim; Björn Andreasson; Peter Johansson; Valérie Jooste; Marc Maynadié; Morgane Mounier; Cédric Rossi; François Girodon
Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.
British journal of haematology 2013;160(2):251-4.
2013: Elisabeth Ejerblad; Hans M Kvasnicka; Eva Löfvenberg; Berit Markevärn; Mats Merup; Lars Nilssson; Jan Palmblad; Jan Samuelsson; Jürgen Thiele; Björn Andreasson; Magnus Björkholm; Gunnar Birgegård
Diagnosis according to World Health Organization determines the long-term prognosis in patients with myeloproliferative neoplasms treated with anagrelide: results of a prospective long-term follow-up.
Hematology (Amsterdam, Netherlands) 2013;18(1):8-13.
2011: Magnus Björkholm; Asa Rangert Derolf; Charlotta Ekstrand; Lynn R Goldin; Fredrik Granath; Malin Hultcrantz; Sigurdur Y Kristinsson; Olle Linder; Claes Malm; Berit Markevärn; Lars Nilsson; Jan Samuelsson; Björn Andreasson; Gunnar Birgegård; Ola Landgren
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(17):2410-5.
2007: Sven Schwemmers; Britta Will; Cornelius F Waller; Khadija Abdulkarim; Peter Johansson; Björn Andreasson; Heike L Pahl
JAK2V617F-negative ET patients do not display constitutively active JAK/STAT signaling.
Experimental hematology 2007;35(11):1695-703.
2006: Mats Merup; Vladimir Lazarevic; Hareth Nahi; Björn Andreasson; Claes Malm; Lars Nilsson; Mats Brune; Katarina LeBlanc; Jack Kutti; Gunnar Birgegård
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens.
British journal of haematology 2006;135(3):367-73.
2005: Philipp S Goerttler; Cordula Steimle; Edith März; Peter L Johansson; Björn Andreasson; Martin Griesshammer; Heinz Gisslinger; Hermann Heimpel; Heike L Pahl
The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients.
Blood 2005;106(8):2862-4.
2005: Philipp L Goerttler; Edith März; Peter L Johansson; Björn Andreasson; Jack Kutti; Alison R Moliterno; Roberto Marchioli; Jerry L Spivak; Heike L Pahl
Thrombotic and bleeding complications in four subpopulations of patients with essential thrombocythemia defined by c-Mpl protein expression and PRV-1 mRNA levels.
Haematologica 2005;90(6):851-3.
2004: Lars Palmqvist; Philipp S Goerttler; Carina Wasslavik; Peter Johansson; Björn Andreasson; Soodabeh Safai-Kutti; Jack Kutti; Heike L Pahl; Anne Ricksten
Comparison of methods for polycythemia rubra vera-1 mRNA quantification in whole-blood leukocytes and purified granulocytes.
Clinical chemistry 2004;50(3):644-7.